Trial Profile
Gardasil Population-Based Condyloma Effectiveness Study In Swedish Women Including Condyloma Incidence Estimations For Swedish Men And Women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer; Condylomata acuminata; Genital warts; Human papillomavirus infections; Penile cancer
- Focus Therapeutic Use
- 21 Mar 2012 New trial record